Pfizer Strategic Investment Holdings LLC, 10% Owner at Cortexyme, Inc. (CRTX), sold 370,000 shares at $40.18 ($14.9M) on 2020-06-03, disclosed to the SEC on 2020-06-04.
Open-market sale of $14.9M CRTX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.